Neurological Conditions

Aculys Pharma, a clinical stage biopharmaceutical company focused on commercializing innovative treatments for neurological conditions, announced the…

Intel is responsibly leveraging artificial intelligence to mitigate risks and drive positive change. Artificial intelligence (AI) has become a…

SBT101 is an investigational gene therapy for adrenomyeloneuropathy (AMN) Oral presentation to showcase dose selection for Phase 1/2…

Partnership further expands Aidoc's AI-based stroke solution, another step in its expansion across the care continuum Aidoc, leading provider of AI…

icometrix, world leader in imaging AI solutions for people with neurological conditions, announced the addition of icobrain cva, a stroke solution, to…

Corlieve Therapeutics announced the closing of its seed financing led by Kurma Partners and IDinvest Partners, together with Pureos Bioventures.…